Spinal Restoration, Inc. Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System

Published: Mar 16, 2010

AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration, Inc. announced today that patient enrollment in the company’s Phase III study of the Biostat System for the treatment of discogenic chronic low back pain is now underway. The study, which will be conducted at 15 U.S. clinical sites, is one of only a few multi-center, randomized, blinded, placebo-controlled trials of a nonsurgical treatment for discogenic low back pain ever to be conducted.

Back to news